Are you Dr. Relkin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
428 E 72nd St
Ofc 500
New York, NY 10021Phone+1 212-746-2441Fax+1 212-746-5584
Summary
- Dr. Norman Relkin, MD is a board certified neurologist in New York, New York. He is currently licensed to practice medicine in New York. He is an Assistant Professor of Neurology at Cornell Univ-Weill Medical College.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1988 - 1991
- New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1987 - 1988
- Albert Einstein College of MedicineClass of 1987
Certifications & Licensure
- NY State Medical License 1991 - 2016
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Join now to see all
Clinical Trials
- Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease Start of enrollment: 2006 Feb 01
- A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease Start of enrollment: 2008 Dec 19
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Publications & Presentations
PubMed
- Is Normal Pressure Hydrocephalus a Complex Genetic Disorder?Norman R Relkin
Neurology. 2024-09-10 - 15 citationsComparison of saliva and nasopharyngeal swab SARS-CoV-2 RT-qPCR testing in a community setting.Monique Torres, Katherine Collins, Mariah Corbit, Maureen Ramirez, Caroline Riley Winters
The Journal of Infection. 2021-04-01 - 28 citationsThe clinical spectrum of hydrocephalus in adults: report of the first 517 patients of the Adult Hydrocephalus Clinical Research Network registry.Michael A. Williams, Sean J. Nagel, Mark G. Luciano, Norman R. Relkin, Thomas J. Zwimpfer
Journal of Neurosurgery. 2020-06-01
Press Mentions
- Anavex Life Sciences : CORPORATE PRESENTATION FEBRUARY 2021March 1st, 2021
- Anavex Soars on Positive Alzheimer’s ResultsJanuary 11th, 2016
- 'Medical Marijuana' Pill Falls Short in Dementia Study - US NewsMay 13th, 2015
- Join now to see all
Grant Support
- Intravenous Immunoglobulin (IVIG) For Treatment Of AD (IVIG)National Institute On Aging2006–2010
- Phase II Study Of IVIG For Alzheimer'S DiseaseNational Center For Research Resources2006–2007
- Risk Evaluation And Education For Alzheimer'S Disease (Reveal Ii)National Center For Research Resources2004–2007
- Effect Of IVIG Dose On Anti-Amyloid Beta Antibody And Amyloid Beta Peptide BloodNational Center For Research Resources2006